ZNRF4: A Potential Drug Target and Biomarker (G148066)

Target Name: ZNRF4

NCBI ID: G148066

ZNRF4

ZNRF4: A Potential Drug Target and Biomarker

Zinc finger nucleosome (Zfn) proteins play a crucial role in various cellular processes, including DNA replication, transcription, and DNA damage repair. ZNRF4, a gene encoding a protein known as Nixin, is a Zfn that is involved in these processes. research has shown that Nixin may have potential as a drug target and biomarker.

The Nixin protein is a 21-kDa protein that is expressed in various tissues, including brain, heart, liver, and muscle. It is composed of a nucleosome core and a C-terminal domain that contains a unique domain called Nixin-1. Nixin-1 is a nucleosome-binding protein that interacts with the core of the nucleosome to form a stable complex. This interaction between Nixin-1 and the nucleosome is critical for the regulation of DNA replication and repair.

Nixin has been shown to play a role in various cellular processes, including the regulation of cell growth, apoptosis, and inflammation. For example, studies have shown that overexpression of Nixin can lead to increased cell proliferation and the formation of cancerous tumors. Additionally, Nixin has been shown to play a role in the regulation of cell apoptosis, which is the process by which cells die naturally. Nixin has been shown to be involved in the regulation of apoptosis by activating the B-cell lymphoma 1 (Bcl-2) gene.

Another study has shown that Nixin is involved in the regulation of inflammation. Nixin has been shown to interact with the transcription factor, NF-kappa-B, to promote the production of pro-inflammatory cytokines. This interaction between Nixin and NF-kappa-B suggests that Nixin may be involved in the regulation of inflammation.

In addition to its role in the regulation of cell processes, Nixin has also been shown to be a potential drug target. The Nixin protein has been shown to interact with various drug molecules, including inhibitors of the DNA replication process, which may make it a useful target for cancer therapies. Additionally, Nixin has been shown to be involved in the regulation of cell apoptosis, which may make it a useful target for therapies that aim to extend the lifespan of cancer cells.

In conclusion, ZNRF4, or Nixin, is a gene encoding a protein that is involved in various cellular processes. Research has shown that Nixin may have potential as a drug target and biomarker. The interaction between Nixin and the nucleosome, as well as its involvement in the regulation of cell growth, apoptosis, and inflammation make it a promising target for future research. Further studies are needed to fully understand the potential of Nixin as a drug target and biomarker.

Protein Name: Zinc And Ring Finger 4

Functions: E3 ubiquitin-protein ligase that acts as a negative regulator of NOD2 signaling by mediating ubiquitination and degradation of RIPK2 (PubMed:28656966). Also catalyzes ubiquitination and proteasomal degradation of CANX within the endoplasmic reticulum (PubMed:21205830). Could have a role in spermatogenesis (By similarity)

The "ZNRF4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNRF4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets